TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Soflin Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
872
|
785
|
818 |
| Financial expenses |
7
|
43
|
22 |
| Earnings before taxes |
170
|
139
|
151 |
| EBITDA |
186
|
186
|
177 |
| Total assets |
558
|
392
|
446 |
| Current assets |
331
|
258
|
246 |
| Current liabilities |
222
|
105
|
204 |
| Equity capital |
301
|
250
|
213 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
53.9%
|
63.8%
|
47.8% |
| Turnover per employee |
436
|
392
|
409 |
| Profit as a percentage of turnover |
19.5%
|
17.7%
|
18.5% |
| Return on assets (ROA) |
31.7%
|
46.4%
|
38.8% |
| Current ratio |
149.1%
|
245.7%
|
120.6% |
| Return on equity (ROE) |
56.5%
|
55.6%
|
70.9% |
| Change turnover |
85
|
33
|
96 |
| Change turnover % |
11%
|
4%
|
13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.